Rheumatology Medical News about systemic sclerosis, fibrosis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cannabinoids inhibit fibrogenesis in diffuse systemic sclerosis fibroblasts
Rheumatology, 07/15/09

Garcia-Gonzalez E et al. - The preliminary findings suggest that cannabinoids are provided with an anti-fibrotic activity, thereby possibly representing a new class of agents targeting fibrosis diseases.

<< Previous
Rituximab in systemic lupus erythematosus: A systematic review of...

Next >>
A pilot risk model for the prediction of rapid radiographic...

Graves' Disease Associated with Primary Systemic Sclerosis
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 11/12/09 Relevance Score: 80%

Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: A cross-sectional study
Journal of Rheumatology, 11/18/09 Relevance Score: 79%

Association of HLA Class II Genes with Systemic Sclerosis in Spanish Patients
Journal of Rheumatology, 11/06/09 Relevance Score: 79%

Autoantibody against one of the antioxidant repair enzymes, methionine sulfoxide reductase A, in systemic sclerosis: association with pulmonary fibrosis and vascular damage
Archives of Dermatological Research, 10/26/09 Relevance Score: 79%

Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09 Relevance Score: 72%